Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.000
-0.100 (-3.23%)
Aug 14, 2025, 11:11 AM - Market open
Compass Therapeutics Revenue
In the year 2024, Compass Therapeutics had annual revenue of $850.00K.
Revenue (ttm)
$850.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
514.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
CMPX News
- 1 day ago - Compass Therapeutics: Finding Their Way With More Positive Updates In BTC - Seeking Alpha
- 1 day ago - Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering - GlobeNewsWire
- 1 day ago - Compass Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 3 days ago - Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - GlobeNewsWire
- 2 months ago - Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha
- 3 months ago - Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewsWire